Tium Bio Venture Capital
2 known investors
Tium Bio develops immunotherapy drugs for treating rare and intractable diseases. The company focuses on oncology indications including head and neck cancer, with a pipeline of differentiated candidates in clinical development.
BiotechDigital HealthMedical Devices
Founders & leadership
KH
Kim Hun-taekCEO